Improved outcomes using tacrolimus/sirolimus for graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplant as treatment of myelofibrosis.

Source:http://linkedlifedata.com/resource/pubmed/id/19786111

Download in:

View as

General Info

PMID
19786111